Publications

Low Her2 Expression Does Not Influence Prognosis in Metastatic Triple-Negative Breast Cancer: Results from an International, Multicenter Analysis Coordinated by the Austrian Group Medical Tumor Therapy (Agmt)

AuthID
P-00W-NJX

Author(s)

Gampenrieder, SP

Dezentje, V

Lambertini, M

de Nonneville, A

Marhold, M

Le Du, F

Serrano, CS

Costa, DA

Blondeaux, E

Del Mastro, L

Bertucci, F

Goncalves, A

Bartsch, R

Deleuze, A

Salgado, AC

Vitorino, M

Tinchon, C

Pecen, L

Rinnerthaler, G

Greil, R

Document Type

Abstract

Year published

2022

Published

in ANNALS OF ONCOLOGY, ISSN: 0923-7534

Volume: 33, Pages: S208-S208 (1)

Indexing

Wos^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1016/j.annonc.2022.03.196

Wos: WOS:000792494100180

Source Identifiers

ISSN: 0923-7534

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

Low Her2 Expression Does Not Influence Prognosis in Metastatic Triple-Negative Breast Cancer: Results from an International, Multicenter Analysis Coordinated by the Austrian Group Medical Tumor Therapy (Agmt)

Useful Links

Get Help

Federated Authentication (Click on the image)

Low Her2 Expression Does Not Influence Prognosis in Metastatic Triple-Negative Breast Cancer: Results from an International, Multicenter Analysis Coordinated by the Austrian Group Medical Tumor Therapy (Agmt)

Useful Links

Get Help